نتائج البحث 401-410 من 14149 لعملية البحث عن pneumococcal disease
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
ug therapy, Chronic kidney disease, Polycystic kidney disease, Acute kidney failure, Kidney failure, End-stage renal disease, Diabetic nephropathy. إظهار ...
This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...
Rochester, Minn., Jacksonville, Fla. Longitudinal Imaging Biomarkers of Disease Progression in Prodromal and Overt DLB.
... disease, with either carcinoma in situ with or without Ta/T1 disease. ... disease including but not limited to suspected lung cancer, mediastinal and ...
Multicentric Castleman disease. Genetic and Rare Diseases Information Center. https://rarediseases.info.nih.gov/diseases/9644/multicentric-castleman-disease.
... disease, Metabolic kidney disease, Renal amyloidosis ... Pneumonia, Tachycardia, Pulmonary edema, Sepsis ... disease, Renovascular disease, Membranoproliferative ...
InPACT-neoadjuvant patients are stratified by disease burden as assessed by radiological criteria. ... disease. . Personalized Neoantigen Peptide-Based Vaccine in ...
Gaucher disease (Type 1). Genetic Disease Foundation. http://www.geneticdiseasefoundation.org/genetic-diseases/gaucher-disease-type-i/. Accessed Jan. 6 ...
Congenital heart disease (CHD) is an abnormal formation that occurs during the development of a baby's heart, heart valves and/or large vessels such as the ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.